ShortageWatch RxUS drug shortage tracker, built on FDA data

← All shortages

Cefepime Hydrochloride Injection shortage

To Be Discontinued  2 presentations · 1 manufacturers · first FDA posting 2026-02-10 · last update 2026-02-10

Manufacturers: Fresenius Kabi USA, LLC

Stated reasons (per FDA): Not stated

📬 Get weekly shortage updates by email

Presentations

PresentationManufacturerStatusReasonNotes (FDA)Dates
Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20)Fresenius Kabi USA, LLCTo Be Discontinued
 —Discontinuation of the manufacture of the drug.Posted 02/10/2026
Updated 02/10/2026
Discontinued 02/10/2026
Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20)Fresenius Kabi USA, LLCTo Be Discontinued
 —Discontinuation of the manufacture of the drug.Posted 02/10/2026
Updated 02/10/2026
Discontinued 02/10/2026

Source: FDA Drug Shortages Database · raw openFDA records

Get the weekly shortage roundup: a free email of FDA shortage changes (open form)